Chronic allograft nephropathy: prospective randomised trial of cyclosporin withdrawal and mycophenolate mofetil or tacrolimus substitution

By McGrath J.S.   Shehata M.  

Transplantation Proceedings, Vol. 33, Iss. 3, 2001-05 ,pp. : 2193-2195

Elsevier

Access to resources Recommend Favorite

Effect of mycophenolate mofetil on progression of chronic allograft nephropathy

By Yeung S.   Lee W.   Tong K.L.   Tsang W.K.   Chan H.W.H.  

Transplantation Proceedings, Vol. 35, Iss. 1, 2003-02 ,pp. : 176-178

Elsevier

Access to resources Recommend Favorite

A randomized trial of mycophenolate mofetil versus azathioprine as calcineurin inhibitor sparing agents in the treatment of chronic allograft nephropathy

By Metcalfe M.S.   Jain S.   Waller J.R.   Saunders R.N.   Bicknell G.R.   Nicholson M.L.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1812-1814

Elsevier

Access to resources Recommend Favorite

Chronic allograft nephropathy: effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease

By Weir M.R.   Fink J.C.   Hanes D.S.   Gardner J.   Klassen D.K.   Cangro C.   Schweitzer E.   Bartlett S.T.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1286-1287

Elsevier

Access to resources Recommend Favorite

Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy

By Park J.H.   Park J.H.   Yang C.W.   Kim Y.-S.   Kim S.Y.   Moon I.S.   Koh Y.B.   Bang B.K.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 1747-1747

Elsevier

Access to resources Recommend Favorite